Medtronic Minimed, Inc.

This study checks if a new insulin pump (NMX8) and glucose sensor are safe for people with type 1 or type 2 diabetes. About 400 participants aged 7 to 85 will use the system for up to 90 days. The goal is to see how well it keeps blood sugar in a healthy range and avoids low bloo…

This study is testing a new implantable insulin pump (MIIPS 2020) in 40 adults with type 1 diabetes whose blood sugar is hard to control with standard insulin shots or external pumps. The pump is placed inside the body and delivers insulin directly, aiming to reduce dangerous hig…